WO2006023296A2 - Alkene polymerization using beta-ketoiminato metal complexes - Google Patents

Alkene polymerization using beta-ketoiminato metal complexes Download PDF

Info

Publication number
WO2006023296A2
WO2006023296A2 PCT/US2005/027927 US2005027927W WO2006023296A2 WO 2006023296 A2 WO2006023296 A2 WO 2006023296A2 US 2005027927 W US2005027927 W US 2005027927W WO 2006023296 A2 WO2006023296 A2 WO 2006023296A2
Authority
WO
WIPO (PCT)
Prior art keywords
compound
group
ethylene
effective amount
comonomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/027927
Other languages
French (fr)
Other versions
WO2006023296A3 (en
Inventor
Geoffrey W. Coates
Yuguo Ma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc filed Critical Cornell Research Foundation Inc
Priority to JP2007527858A priority Critical patent/JP2008510001A/en
Priority to US11/629,985 priority patent/US20090192278A1/en
Publication of WO2006023296A2 publication Critical patent/WO2006023296A2/en
Publication of WO2006023296A3 publication Critical patent/WO2006023296A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F10/00Homopolymers and copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F110/00Homopolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F110/02Ethene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F110/00Homopolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F110/04Monomers containing three or four carbon atoms
    • C08F110/06Propene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F210/00Copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F210/02Ethene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F210/00Copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F210/04Monomers containing three or four carbon atoms
    • C08F210/06Propene

Definitions

  • This invention is directed to group (IV) and group (X) metal complexes with beta- ketoiminato ligands and to the use of these complexes as catalysts for polymerization of ethylene, C 3 -Cio-alpha olefins, C4-C 10 cyclic alkenes and for the copolymerization of ethylene and comonomers.
  • Group (IV) and group (X) metal complex catalysts with beta-ketoiminato ligands for use for polymerizing ethylene and alpha olefins are known. See Kim, J., et al, Journal of Organometallic Chemistry 620, 1-7 (2001); Li, X.-F., et al, Organometallics 23, 1223-1230 (2004); Zhang, D., et al, Organometallics 23, 3270-3275 (2004).
  • M is selected from the group consisting of titanium, zirconium and hafnium;
  • X is selected from the group consisting of halogens, Ci-C 20 hydrocarbons, Ci-C 20 alkoxides and Ci-C 20 amides;
  • R is selected from the group consisting of hydrogen, Ci-C 2O hydrocarbons, Ci-C 2O fluorocarbons (includes, for example, fluoroalkyls and fluoroaryls including those with both H and F substituents) and C 3 -C 20 heterocycles;
  • R 1 is selected from the group consisting Of C 2 -C 20 hydrocarbons bound by a tetrahedral carbon atom, i.e., where carbon alpha to carbonyl carbon, i.e., the carbon bonded to oxygen of ketoimine moiety is a tetrahedral carbon;
  • R 2 is selected from the group consisting of hydrogen, Ci-C 20 hydrocarbons, Ci-C 20 fluorocarbons (
  • M is selected from the group consisting of nickel and palladium
  • L is a neutral two electron donor (i.e., an uncharged group which fulfills the function of filling the coordination valance of M, e.g., an ether, phosphine or nitrile group)
  • X, R, R 1 , R 2 and R 3 are defined as above and where two or more of R, R 1 , R 2 and R 3 can be bonded together to form a ring.
  • R 1 and R 2 are bonded together thereby forming (arylimino-alkyl)- spiro[4,5]decan-6-one ligand (two for (I) and one for (H)), i.e., to contain spiro[4,5]decane-6- onato moiety.
  • the compounds have the structure:
  • R and R 3 are defined as above and R and R 3 can be bonded together to form a ring or have the structure:
  • R and R 3 are defined as above and R and R 3 can be bonded together to form a ring.
  • X is Cl
  • R is H or CF 3 and R 3 is phenyl or fluorinated phenyl and even more preferably the compound contains at least one fluorine atom.
  • the compounds (I), (II), (III) and (IV) are useful as catalysts for polymerization of ethylene, C 3 -Ci 0 alpha olefins, and C 4 -Ci 0 cyclic alkenes and for copolymerizing ethylene and comonomer selected from the group consisting of C 3 -Ci 0 alpha olefins, styrene, C 3 -Ci 0 dienes, C 3 -Ci 0 alkenyl halides and C 4 -Ci 0 cyclic alkenes.
  • ethylene is polymerized in the presence of a catalytically effective amount of activated compound (I), e.g., activated compound (III), to produce polyethylene of M n in the range of 1,000 to 3,000,000 and polydispersities (PDI) in the range of 1 to 3.
  • activated compound (I) e.g., activated compound (III)
  • PDI polydispersities
  • C 3 -Ci O alpha olefin is polymerized in the presence of a catalytically effective amount of activated compound (I), e.g., activated compound (III), to produce poly(C 3 -Ci 0 alpha olefin) Of M n ranging from 1,000 to 3,000,000 and PDI ranging from 1 to 3.
  • activated compound (I) e.g., activated compound (III)
  • M n ranging from 1,000 to 3,000,000 and PDI ranging from 1 to 3.
  • C 4 -Ci 0 cyclic alkene is polymerized in the presence of a catalytically effective amount of activated compound (I), e.g., activated compound (III), to produce PoIy(C 4 -Ci O cyclic alkene) of M n ranging from 1,000 to 3,000,000 and PDI ranging from 1 to 3.
  • activated compound (I) e.g., activated compound (III)
  • ethylene and comonomer in a mole ratio of ethylene to comonomer ranging from 1 :99 to 99:1 are copolymerized in the presence of a catalytically effective amount of activated compound (I), e.g., activated compound (III), to produce copolymer of ethylene and said comonomer of M n ranging from 1,000 to 3,000,000.
  • activated compound (I) e.g., activated compound (III)
  • the polymerizations/copolymerizations are advantageously carried out with the activation being effected by an activating effective amount of methylaluminoxane such that [Al]:[Ti] mole ratio ranges from 100 to 200:1; e.g., 125 to 175: 1.
  • the polymerizations/copolymerizations are carried out with the activation being effected by an activating effective amount of methylaluminoxane of compounds of the first embodiment herein such that [Al]: [Zr] mole ratio ranges from 100 to 200: 1; e.g., 150: 1.
  • the polymerization/copolymerization are advantageously carried out with the activation being effected by an activating effective amount of methylaluminoxane such that [Al]: [Hf] mole ratio ranges from 100 to 200:1; e.g., 150:1.
  • the said polymerizations/copolymerizations can also be carried out in the presence of an activating effective amount of trialkylaluminum/fluorinated borate salts, such as i- Bu 3 Al/Ph 3 C + B(C 6 F 5 ) 4 ⁇ such that [Al]: [B]: [M] mole ratio ranges from 10 to 100:2: 1; e.g., 40:2:1.
  • the molecular weights and polydispersities (PDI) are determined by high temperature gel-permeation chromatography using monodisperse polyethylene standards.
  • R is H
  • the spiroketone (VI) is first formylated using ethyl formate to generate aldehyde which is coupled with R 3 NH 2 under neat conditions in the presence of p-toluenesulfonic acid and phosphorus pentoxide to generate ligand whereupon deprotonation followed by reaction with MX 4 as described above gives compound (III).
  • (V) is deprotonated in solvent, e.g., at -78°C with one equivalent of butyllithium followed by reaction with one equivalent trans- [(L) 2 NiX(Cl)].
  • the amount of compound (I) or compound (II) per mole of monomer ranges, for example, from 1 to IxIO "6 mmol per mole; i.e., this amount can provide catalytically effective amount.
  • the methylaluminoxane mentioned above is an activator for compounds (I)/(III).
  • methylaluminoxane reaction with a metal alkyl such as AlR 3 or ZnR 2 followed by reaction with (Ph 3 C) (BAr 4 ), (PhNMe 2 H) (BAr 4 ), Ar 3 B or Ar 3 Al, e.g., trialkylaluminum/fluorinated borate salts, e.g., z-Bu 3 Al/Ph 3 C + B(C 6 F 5 ) 4 ⁇
  • Activators for compounds (II)/(IV) are Lewis acids such as (l,5-cyclooctadiene)Ni, Ar 3 B or Ar 3 Al.
  • activator means any compound that reacts with (I) or (II) to generate an active catalytic species in situ and the term “activated” means that (I) or (II) has been reacted with activator to convert M of (I) or (II) to cationic form and/or to cause rearrangement of (I) or (II) to a more active or selective form.
  • Amounts are given above exemplary for methylaluminoxane activating effective amount.
  • Reaction times typically range from 5 minutes to 1 hour.
  • Reaction temperatures can range, e.g., from 0 to 5O 0 C.
  • a suitable solvent for the catalyst for the polymerizations/copolymerizations is toluene.
  • Ti complex Ia The Ti complex Ia was synthesized following the procedure similar to that reported in literature to make phenoxyimine Ti complex with minor modifications.
  • ligand 7-(2,2,2-trifluoro-l-phenylimino-ethyl)-spiro[4,5]decan- 6-one (1.29 g, 3.98 mmol) in 20 mL of diethyl ether (Et 2 O) at -78 0 C was added H-BuLi (1.6 M in hexanes, 2.48 niL, 3.98 mmol) dropwise using a gas tight syringe.
  • This solution was allowed to slowly return to room temperature and stirred for an additional half hour.
  • Ti complex Ib The Ti complex Ib was synthesized following the procedure to make Ia. Thus, ligand 7-[l-(2,6-difluoro-phenylimino)-2,2,2-trifluoro-ethyl]-spiro[4,5]decan-6- one (0.57 g, 1.59 mmol) was reacted with «-BuLi (1.6 M in hexanes, 0.99 mL, 1.59 mmol) and then TiCl 4 (1.0 M in toluene, 0.8 mL, 0.8 mmol) to give a deep red powder that was crystallized from a mixture of toluene/pentane to give the desired complex as a deep red crystalline solid (0.15g, 23%).
  • «-BuLi 1.6 M in hexanes, 0.99 mL, 1.59 mmol
  • TiCl 4 1.0 M in toluene, 0.8 mL, 0.8 mmol
  • Ti complex Ic The Ti complex Ic was synthesized following the procedure to make Ia. Thus, ligand 7-phenyliminomethyl-spiro[4,5]decan ⁇ 6-one (1.24 g, 4.86 mmol) was reacted with «-BuLi (1.6 M in hexanes, 3.03 mL, 4.86 mmol) and then TiCl 4 (1.0 M in toluene, 2.43 mL, 2.43 mmol) to give a deep read powder (81 mg, 6%).
  • «-BuLi 1.6 M in hexanes, 3.03 mL, 4.86 mmol
  • TiCl 4 1.0 M in toluene, 2.43 mL, 2.43 mmol
  • Ti complex Id The Ti complex Id was synthesized following the procedure to make Ia. Thus, ligand 7-[(2,6-difluoro-phenylimino)-methyl-spiro[4,5]decan-6-one (1.03 g, 3.54 mmol) was reacted with «-BuLi (1.6 M in hexanes, 2.21 mL, 3.54 mmol) and then TiCl 4 (1.0 M in toluene, 1.77 mL, 1.77 mmol) gave a deep red powder that was crystallized from toluene to give the desired complex as a deep red crystalline solid (0.83g, 67%).
  • «-BuLi 1.6 M in hexanes, 2.21 mL, 3.54 mmol
  • TiCl 4 1.0 M in toluene, 1.77 mL, 1.77 mmol
  • Ti complex Ie The Ti complex Ie was synthesized following the procedure to make Ia. Thus, ligand 7-[(3,5-difluoro-phenylimino)-methyl]-spiro[4.5]decan-6-one (0.68 g, 2.33 mmol) was reacted with «-BuLi (1.6 M in hexanes, 1.46 mL, 2.33 mmol) and then TiCl 4 (1.0 M in toluene, 1.17 mL, 1.17 mmol) to give a deep red powder that was crystallized from toluene to give the desired complex as a deep red crystalline solid (0.088 g, 11%).
  • «-BuLi 1.6 M in hexanes, 1.46 mL, 2.33 mmol
  • TiCl 4 1.0 M in toluene, 1.17 mL, 1.17 mmol
  • Ti complex If was synthesized following the procedure to make Ia.
  • ligand 7-[(pentafluorophenylimino)-methyl]-spiro[4,5]decan-6-one (1.08 g, 3.13 mmol) was reacted with «-BuLi (1.6 M in hexanes, 1.96 mL, 3.13 mmol) and then TiCl 4 (1.0 M in toluene, 1.57 mL, 1.57 mmol) to give a deep red powder that was crystallized from toluene to give the desired complex as a deep red crystalline solid (0.80 g, 63%).
  • Compound Ig is synthesized as follows: The ligand 7-(2,2,2-trifluoro-l-phenylimino- ethyl)-spiro[4.5]decane-6-one is synthesized as described in Example I. A solution of the ligand in toluene is added to a solution of tetrakis(dimethylamino) zirconium in toluene solvent at room temperature, leading to an immediate color change from light yellow to orange, and then dark red. The resulting solution is stirred overnight to afford after solvent removal the complex L 2 Zr(NMe 2 ) 2 . Then the complex L 2 Zr(NMe 2 ) 2 is dissolved in methylene chloride, and an excess (ca. 10 equivalent) of chlorotrimethylsilane is added. After stirring overnight at 22°C, the solvent is removed under vacuum. The dark red residue is triturated with pentane to afford a yellow solid.
  • Compound Ih is synthesized as follows: The ligand 7-(2,2,2-trifluoro-l- phenylimino-ethyl)-spiro[4,5]decane-6-one is synthesized as described in Example I. A solution of the ligand in toluene is added to a solution of tetrakis(dimethylamino) hafnium in toluene solvent at room temperature, leading to an immediate color change. The resulting solution is stirred overnight to afford after solvent removal the complex L 2 Hf(NMe 2 ) 2 . Then the complex L 2 Hf(NMe 2 ) 2 is dissolved in methylene chloride, and an excess (ca. 10 equivalent) of chlorotrimethylsilane is added. After stirring overnight at 22 0 C, the solvent is removed under vacuum. The residue is triturated with pentane to afford compound Ih as a solid.
  • Compound Ii is synthesized as follows: The ligand 7-(2,2,2-trifiuoro-l-phenylimino- ethyl)-spiro[4,5]decane-6-one is synthesized as set forth in Example I. The ligand is deprotonated in toluene solvent with one equivalent n-butyllithium at -78 0 C. Then one equivalent of /ra «s-[(Ph 3 P)2NiPh(Cl)] in toluene is added. After stirring overnight at 22 0 C, the suspension is filtered to remove LiCl. Upon concentration of the toluene, crystals of Compound Ii are grown and isolated after decanting the mother liquor.
  • the 13 C I N NMMRR a annaallyyssiis indicates that these PE samples have linear structures with non- detectable branching.
  • Polymerization is conducted m a 3-ounce Lab-CrestTM pressure reaction vessel equipped with a magnetic stir bar
  • the reactor is first conditioned under dynamic vacuum and high temperature and then charged with a 3 mmol of PMAO in toluene and 5 mL of cyclopentene under nitrogen.
  • 20 mmol of CAT is dissolved in toluene (3 mL) at room temperature under nitrogen
  • the solution is then added to the reactor using a syringe.
  • the reactor is adjusted at 70 0 C After 16 h, the reactor contents are poured into methanol/HCl and polymer is isolated by filtration.
  • Polymerization is conducted in a 3-ounce Lab-CrestTM pressure reaction vessel equipped with a magnetic stir bar.
  • the reactor is under dynamic vacuum and high temperature and then charged with a 3 mmol of PMAO in toluene and 5 mL of norbornene under nitrogen Then 20 mmol of CAT is dissolved in toluene (3 mL) at room temperature under nitrogen The solution is then added to the reactor using a syringe. Finally, the reactor is adjusted at 70 0 C. After 16 h, the reactor contents are poured into methanol/HCl and polymer is isolated by filtration.
  • Polymerization is conducted in a 3-ounce Lab-CrestTM pressure reaction vessel equipped with a magnetic stir bar.
  • the reactor is charged with 6 mmol of PMAO in toluene under nitrogen.
  • 13.2 mL of cyclopentene is introduced.
  • CAT is dissolved in toluene (5 mL) at room temperature under nitrogen.
  • the solution is then added to the reactor via syringe, such that the fixed [A1]/[M] ratio is 150.
  • the reactor is pressurized with ethylene gas and adjusted to the desired pressure and temperature. After the desired period of time, the reactor is vented.
  • the polymer is precipitated from methanol/HCl, filtered, and then dried in vacuo to constant weight.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

Group (IV) and (X) metal complexes with ketoiminate ligands are prepared by deprotonation of a ketoimine ligand followed by reaction with the appropriate metal halide. In preferred cases, the compounds are titanium (IV), zirconium (IV) and hafnium (IV), preferred cases, the compounds are titanium (IV), zirconium (IV) and hafnium (IV) complexes with (arylimino-alkyl)-spiro[4,5]decan-6-one ligands. The compounds are useful as catalysts for polymerizing ethylene, C3-C10-alpha olefins and C4-C10 cyclic alkenes and for copolymerizing ethylene with comonomers.

Description

Alkene Polymerization using Beta-Ketoiminato Metal Complexes
The invention was made at least in part with United States Government support under National Science Foundation related grant CCMR (Cornell Center for Materials Research) Grant Number DMR 0079992. The United States Government has certain rights in the invention.
Cross-Reference to Related Applications
This application claims the benefit of U.S. Provisional Application No. 60/602,320, filed August 18, 2004, the whole of which is incorporated herein by reference.
Technical Field
This invention is directed to group (IV) and group (X) metal complexes with beta- ketoiminato ligands and to the use of these complexes as catalysts for polymerization of ethylene, C3-Cio-alpha olefins, C4-C10 cyclic alkenes and for the copolymerization of ethylene and comonomers.
Background of the Invention
Group (IV) and group (X) metal complex catalysts with beta-ketoiminato ligands for use for polymerizing ethylene and alpha olefins are known. See Kim, J., et al, Journal of Organometallic Chemistry 620, 1-7 (2001); Li, X.-F., et al, Organometallics 23, 1223-1230 (2004); Zhang, D., et al, Organometallics 23, 3270-3275 (2004).
These efforts have focused on complexes with beta-ketoiminato ligands, where carbon alpha to the carbonyl carbon is planar (sp2-hybridized) or methyl or trifluoromethyl.
A new family of ligands is important to enrich the pool for catalyst discovery. Summary of the Invention
It has been discovered herein that a new family of ligands is available where a carbon alpha to a carbonyl carbon is a tetrahedral carbon, that is a carbon which has four bonds extending in different directions.
In an embodiment of the invention, denoted the first embodiment, there is provided a compound having the structure:
Figure imgf000003_0001
where M is selected from the group consisting of titanium, zirconium and hafnium; where X is selected from the group consisting of halogens, Ci-C20 hydrocarbons, Ci-C20 alkoxides and Ci-C20 amides; where R is selected from the group consisting of hydrogen, Ci-C2O hydrocarbons, Ci-C2O fluorocarbons (includes, for example, fluoroalkyls and fluoroaryls including those with both H and F substituents) and C3-C20 heterocycles; where R1 is selected from the group consisting Of C2-C20 hydrocarbons bound by a tetrahedral carbon atom, i.e., where carbon alpha to carbonyl carbon, i.e., the carbon bonded to oxygen of ketoimine moiety is a tetrahedral carbon; R2 is selected from the group consisting of hydrogen, Ci-C20 hydrocarbons, Ci-C20 fluorocarbons (includes, for example, fluoroalkyls and fluoroaryls including those with both H and F substituents) and C3-C20 heterocycles; R3 is selected from the group consisting Of C]-C20 hydrocarbons, Ci-C20 fluorocarbons (includes, for example, fluoroalkyls and fluoroaryls including those with both H and F substituents) and C3-C20 heterocycles; where two or more of R, R1, R2 and R3 can be bonded together to form a ring; or having the structure:
Figure imgf000004_0001
where M is selected from the group consisting of nickel and palladium, L is a neutral two electron donor (i.e., an uncharged group which fulfills the function of filling the coordination valance of M, e.g., an ether, phosphine or nitrile group), X, R, R1, R2 and R3 are defined as above and where two or more of R, R1, R2 and R3 can be bonded together to form a ring.
In preferred cases, R1 and R2 are bonded together thereby forming (arylimino-alkyl)- spiro[4,5]decan-6-one ligand (two for (I) and one for (H)), i.e., to contain spiro[4,5]decane-6- onato moiety. In this case, the compounds have the structure:
Figure imgf000004_0002
where M is selected from the group consisting of titanium, zirconium, and hafnium, and R and R3 are defined as above and R and R3 can be bonded together to form a ring or have the structure:
Figure imgf000004_0003
where M is selected from the group consisting of nickel and palladium and L, R and R3 are defined as above and R and R3 can be bonded together to form a ring.
Preferably X is Cl, R is H or CF3 and R3 is phenyl or fluorinated phenyl and even more preferably the compound contains at least one fluorine atom. The compounds (I), (II), (III) and (IV) are useful as catalysts for polymerization of ethylene, C3-Ci0 alpha olefins, and C4-Ci0 cyclic alkenes and for copolymerizing ethylene and comonomer selected from the group consisting of C3-Ci0 alpha olefins, styrene, C3-Ci0 dienes, C3-Ci0 alkenyl halides and C4-Ci0 cyclic alkenes.
In another embodiment of the invention, denoted the second embodiment, ethylene is polymerized in the presence of a catalytically effective amount of activated compound (I), e.g., activated compound (III), to produce polyethylene of Mn in the range of 1,000 to 3,000,000 and polydispersities (PDI) in the range of 1 to 3.
In still another embodiment of the invention, denoted the third embodiment, C3-CiO alpha olefin is polymerized in the presence of a catalytically effective amount of activated compound (I), e.g., activated compound (III), to produce poly(C3-Ci0 alpha olefin) Of Mn ranging from 1,000 to 3,000,000 and PDI ranging from 1 to 3.
In still another embodiment of the invention, denoted the fourth embodiment, C4-Ci0 cyclic alkene is polymerized in the presence of a catalytically effective amount of activated compound (I), e.g., activated compound (III), to produce PoIy(C4-CiO cyclic alkene) of Mn ranging from 1,000 to 3,000,000 and PDI ranging from 1 to 3.
In still another embodiment of the invention, denoted the fifth embodiment, ethylene and comonomer in a mole ratio of ethylene to comonomer ranging from 1 :99 to 99:1 are copolymerized in the presence of a catalytically effective amount of activated compound (I), e.g., activated compound (III), to produce copolymer of ethylene and said comonomer of Mn ranging from 1,000 to 3,000,000.
Where M is Ti and X is Cl, the polymerizations/copolymerizations are advantageously carried out with the activation being effected by an activating effective amount of methylaluminoxane such that [Al]:[Ti] mole ratio ranges from 100 to 200:1; e.g., 125 to 175: 1.
Where M is Zr and X is Cl, the polymerizations/copolymerizations are carried out with the activation being effected by an activating effective amount of methylaluminoxane of compounds of the first embodiment herein such that [Al]: [Zr] mole ratio ranges from 100 to 200: 1; e.g., 150: 1.
Where M is Hf and X is Cl, the polymerization/copolymerization are advantageously carried out with the activation being effected by an activating effective amount of methylaluminoxane such that [Al]: [Hf] mole ratio ranges from 100 to 200:1; e.g., 150:1. The said polymerizations/copolymerizations can also be carried out in the presence of an activating effective amount of trialkylaluminum/fluorinated borate salts, such as i- Bu3Al/Ph3C+B(C6F5)4 ~ such that [Al]: [B]: [M] mole ratio ranges from 10 to 100:2: 1; e.g., 40:2:1.
The molecular weights and polydispersities (PDI) are determined by high temperature gel-permeation chromatography using monodisperse polyethylene standards.
Detailed Description
We turn now to the first embodiment of the invention. We turn now to synthesis of compounds of the structure (I).
Figure imgf000006_0001
(V) where R, R1, R2 and R3 are defined as for structure (I), is deprotonated in solvent, e.g., at - 780C with 1 equivalent of butyllithium followed by reaction with MX4. The lithium of BuLi replaces the H in (V) and 2 Lig-Li + MX4 gives (Lig)2 MX2 + 2 LiX.
We turn now to synthesis of the compounds of the structure (III). Spiroketone (VI)
Figure imgf000006_0002
is obtained, for example, through a pinacol rearrangement from [l,l'-bicyclopentyl]-l,r-diol. This synthesis is described in Kita, Y., et al., Tetrahedron Lett 38, 8315-8318 (1997) and Kita, Y., Tetrahedron 54, 14689-14704 (1998). Where R3 is Ci-C20 hydrocarbon or Ci-C20 fluorocarbon, coupling Of R3N=C(R)Cl with spiroketone generates the corresponding ligand whereupon deprotonation followed by reaction with MX4 as described above gives compound (III). The compound R3N=C(R)Cl is prepared by reacting R3NH2 and RC(O)OH in CCl4 with Ph3P and Et3N. Where R is H, the spiroketone (VI) is first formylated using ethyl formate to generate aldehyde which is coupled with R3NH2 under neat conditions in the presence of p-toluenesulfonic acid and phosphorus pentoxide to generate ligand whereupon deprotonation followed by reaction with MX4 as described above gives compound (III). We turn now to synthesis of the compounds of the structure (II).
Figure imgf000007_0001
(V) is deprotonated in solvent, e.g., at -78°C with one equivalent of butyllithium followed by reaction with one equivalent trans- [(L)2NiX(Cl)].
We turn now to synthesis of the compounds (IV). Ligand is formed as described above for (III). Deprotonation, followed by reaction with trans- [(L)2NiX(Cl)] gives (IV).
We turn now to the method embodiments of the invention herein.
The amount of compound (I) or compound (II) per mole of monomer ranges, for example, from 1 to IxIO"6 mmol per mole; i.e., this amount can provide catalytically effective amount.
The methylaluminoxane mentioned above is an activator for compounds (I)/(III).
Alternatives for the methylaluminoxane are reaction with a metal alkyl such as AlR3 or ZnR2 followed by reaction with (Ph3C) (BAr4), (PhNMe2H) (BAr4), Ar3B or Ar3Al, e.g., trialkylaluminum/fluorinated borate salts, e.g., z-Bu3Al/Ph3C+B(C6F5)4\
Activators for compounds (II)/(IV) are Lewis acids such as (l,5-cyclooctadiene)Ni, Ar3B or Ar3Al.
As used herein, the term "activator" means any compound that reacts with (I) or (II) to generate an active catalytic species in situ and the term "activated" means that (I) or (II) has been reacted with activator to convert M of (I) or (II) to cationic form and/or to cause rearrangement of (I) or (II) to a more active or selective form.
Amounts are given above exemplary for methylaluminoxane activating effective amount.
Reaction times typically range from 5 minutes to 1 hour.
Reaction temperatures can range, e.g., from 0 to 5O0C.
A suitable solvent for the catalyst for the polymerizations/copolymerizations is toluene.
The invention is illustrated in the following working examples. Example I
Synthesis of (III) where M is Ti, X is Cl, R is CF2. R3 is Ph - Compound Ia.
This synthesis is set forth below. This compound is sometimes designated "CAT" hereinafter.
7-(2,2,2-Trifluoro-l-phenylimino-ethyl)-spiro [4,5] decan-6-one. A procedure similar to that used to make TV-substituted β-enamino acid derivatives from 2-alkyl-2- oxazolines and N-arylimidoyl chloride as described in Fustero, S., et al., J. Org. Chem. 61, 8849-8859 (1996), was used. Thus, to a stirred solution of diisopropylamine (2.8 niL, 20 mmol) in THF (15 mL) at 00C was added «-butyllithium (1.6 M in hexanes, 12.5 mL, 20 mmol) dropwise. After being stirred for an additional 30 min. the solution was cooled to - 78°C and spiro[4,5]-decane-6-one (1.52g, 10 mmol) in THF (15 ml) was added. The reaction mixture was stirred for 2 h, then lifted from the dry ice/acetone bath to warm to room temperature (RT) for 20 min. After cooling down to -780C, a solution of the /V-phenyl-2,2,2- trifluoroacetimidoyl chloride (2.07g, 10 mmol) in THF (15 mL) was slowly added to the reaction mixture. When TLC analysis showed the disappearance of the starting material, the reaction was quenched by saturated ammonium chloride aqueous solution. The aqueous layer was extracted with CH2Cl2 (25 mL x 3). The combined organic layers were washed with brine and dried over Na2SO4. After filtration, the solvents were removed under reduced pressure to furnish the crude product as brown oil. Purification by column chromatography over silica gel (5-7% (v/v) ethyl acetate/hexanes, Rf=O.5) afforded 1.3g (41%) of pure product as a yellow oil. 1H NMR (300 MHz): δlθ.95 (s, 0.5H, OH/CH), 7.24 (m, 2H, ArH), 7.08 (t, J = 7.5, 1Η, ArH), 6.95 (d, J = 8.1, 2Η, ArH), 5.54 (brs, 0.1Η, CH/OΗ), 2.70 (m, 2Η, CH2), 2.31-2.03 (m, 2Η, CH2), 1.86-1.80 (m, 4Η, CH2), 1.73-1.66 (m, 4Η, CH2), 1.51-1.39 (m, 2Η, CH2). 13C NMR (75 MHz): δ 208.5, 142.5, 129.2, 128.0, 124.1, 121.7, 119.7, 116.4, 56.2, 40.2, 38.6, 37.1, 35.2, 26.1, 21.7. 19F NMR (282 MHz): δ -68.3.
Ti complex Ia. The Ti complex Ia was synthesized following the procedure similar to that reported in literature to make phenoxyimine Ti complex with minor modifications. Thus, to a stirred solution of ligand 7-(2,2,2-trifluoro-l-phenylimino-ethyl)-spiro[4,5]decan- 6-one (1.29 g, 3.98 mmol) in 20 mL of diethyl ether (Et2O) at -780C was added H-BuLi (1.6 M in hexanes, 2.48 niL, 3.98 mmol) dropwise using a gas tight syringe. This solution was allowed to slowly return to room temperature and stirred for an additional half hour. The solution was then added dropwise via cannula to a solution of TiCl4 (1.0 M in toluene, 2.0 mL, 2.0 mmol) in Et2O (15 mL) at -78°C. The resulting deep red solution was allowed to warm naturally to room temperature and stirred for an additional 16 h. After removal of the solvent under vacuum, the residue was taken up in toluene and the precipitated LiCl was removed by filtration over a Celite plug. Removal of solvent in vacuo gave a deep red powder that was crystallized from a mixture of toluene/pentane to give the desired complex as a deep red crystalline solid (1.02 g, 67%). 1H NMR (toluene-</8, 500 MHz): δ 7.14 (d, J = 7.0, 2H, ArH), 7.03 (t, J = 7.8, 2Η, ArH), 6.92 (t, J = 7.2, 2Η, ArH), 6.84 (t, J = 7.2, 2Η, ArH), 6.72 (d, J = 7.0, 2Η, ArH), 2.68 (m, 2Η, CH2), 2.48 (m, 2Η, CH2), 1.93 (m, 2Η, CH2), 1.81 (m, 2Η, CH2), 1.47-1.32 (m, 16Η, CH2), 1.11 (m, 2Η, CH2), 0.77 (m, 2Η, CH2). 13C NMR (toluene-^, 125 MHz): δ 187.4, 159.6 (q, JCF = 26.4), 150.2, 126.5, 122.7, 122.5, 120.1, 113.4, 51.3, 40.8, 40.1, 37.5, 27.7, 21.6. 19F NMR (toluene-J8, 470 MHz): δ -60.0.
Example II
Synthesis of (III) where M is Ti, X is Cl, R is CF3. R3 is 2.6-F?Ph - Compound Ib
This synthesis is set forth below.
7V-(2,6-Difluoro-phenyl)-2,2,2-trifluoro-acetimidoyl chloride. The procedure used to make N-phenyl analogue was followed. Thus, 2,6-difluoroaniline (5.17 mL, 6.20 g, 48 mmol) was reacted with trifluoroacetic acid (TFA, 3.08 mL, 4.56 g, 40 mmol) and carbon tetrachloride (CCl4 38.6 mL, 61.50 g, 400 mmol) in the presence of triphenylphosphine (Ph3P, 31.47 g, 120 mmol) and triethylamine (Et3N, 6.70 mL, 4.86 g, 48 mmol) under reflux condition for 6 h afforded 3.70 g (38%) of pure product as a colorless oil after vacuum distillation (54°C/240 mTorr). 1H NMR (C6D6, 500 MHz): δ 6.35 (d, J = 9.1, 2H, ArH-3,5), 6.33 (t, J=9.0, 1Η, ArH-4). 13C NMR (C6D6, 125 MHz): δ 153.0 (dd, 'jCF = 251.7, 3JCF = 4.2, ArC, orthό), 140.3 (N=C), 128.2, 122.4 (t, 3JCF = 16.0, AcC, para), 117.5 (q, 1J0P = 278.0, CF3), 1 12.3 (dd, 2JCF = 18.3, 4JCF = 4.6, ArC, meta). 19F NMR (C6D6, 470 MHz): δ -71.8, - 121.0. 7-[l-(2,6-Difluoro-phenylimino)-2,2,2-trifluoro-ethyl]-spiro[4,5]decan-6-one. The procedure used to make iV-phenyl analogue was followed. Thus, spiro[4,5]decan-6-one was reacted with diisopropylamine (2.8 mL, 2.02 g, 20 mmol) and «-BuLi (1.6 M in hexane, 12.5 mL, 20 mmol) in THF at -78°C, and then N-(2,6-diflouro-phenyl)-2,2,2-trifluoro-acetimidoyl chloride (2.44 g, 10 mmol) to afford 0.51 g (15%) of pure product as a yellow oil. 1H NMR (300 MHz): δ 1 1.08 (s, IH, OH/CH), 7.03 (m, IH, ArH), 6.90 (m, 2Η, ArH), 2.65 (brs, 2Η, CH2), 2.00-1.42(m, 12Η, CH2). 13C NMR (75 MHz): δ 222.9, 221.9, 208.9, 125.1, 1 12.5, 11 1.8, 111.7, 1 11.5, 56.0, 38.8, 37.0, 27.1, 26.2, 21.9.
Ti complex Ib. The Ti complex Ib was synthesized following the procedure to make Ia. Thus, ligand 7-[l-(2,6-difluoro-phenylimino)-2,2,2-trifluoro-ethyl]-spiro[4,5]decan-6- one (0.57 g, 1.59 mmol) was reacted with «-BuLi (1.6 M in hexanes, 0.99 mL, 1.59 mmol) and then TiCl4 (1.0 M in toluene, 0.8 mL, 0.8 mmol) to give a deep red powder that was crystallized from a mixture of toluene/pentane to give the desired complex as a deep red crystalline solid (0.15g, 23%). 1H NMR (toluene-<4 400 MHz): δ 6.55 (m, 4H, ArH), 6.40 (m, 2Η, ArH), 2.80-0.80 (m, 28Η, CH2). 13C NMR (toluene-J8, 100 MHz): δ 189.2, 127.8, 122.3, 119.4, 113.1, 112.5, 112.3, 111.6, 51.6, 40.9, 39.9, 37.4, 27.0, 21.4. 19F NMR (toluene- J8, 376 MHz): δ -60.8, -113.2, -116.4. Anal Calcd for C36H34Cl2F10N2O2Ti: C, 51.76; H, 4.10; N, 3.35. Found: C, 51.59; H, 4.17; N, 3.10.
Example III
Synthesis of (III) where M is Ti, X is Cl, R R i iss H H a anndd ] R "3 is Ph - Compound Ic
This synthesis is set forth below.
6-Oxo-spiro[4,5]decane-7-carbaldehyde. The procedure similar to that reported in Lopez- Alvarada, P., et al., Eur. J. Org. Chem. 2002, 1702-1707 for formylation under basic conditions was followed. A solution of spiro[4,5]decan-6-one(2.70 g, 17.74 mmol) in dry toluene (40 mL) was added dropwise by a gas tight syringe at room temperature to a suspension of sodium methoxide (4.29 g, 75.44 mmol) in dry toluene (75 mL). The reaction mixture turned from white to pale yellow and was cooled to 00C. After 20 min, ethyl formate (6.12 mL, 5.61 g, 75.73 mmol) was added dropwise by a gas tight syringe, and the reaction mixture was stirred at room temperature overnight. Diethyl ether (80 mL) was then added, and the suspension was washed with water (40 mL x 2) and was titrated to pH = 6 by 2N HCl (aq.)- The ethereal solution was dried over Na2SO4, filtered, and concentrated under reduced pressure to yield 3.04 g (95%) product as a light yellow oil. 1H NMR (300 MHz): δ 14.79 (d, J = 3.3, IH, OHICH), 8.62 (d, J = 3.3, IH, CHO), 2.33 (t, J = 6.2, 2Η, CH2), 2.12-1.42(m, 12Η, CH2). 13C NMR (75 MHz): δ 191.4, 187.8, 108.1, 48.9, 39.3, 36.2, 26.5, 24.1, 20.7.
7-Phenyliminomethyl-spiro[4,5]decan-6-one. A 150 mL round bottom flask was charged with spiroaldehyde (1.00 g, 5.55 mmol), aniline (0.65 g, 6.93 mmol) and the mixture was stirred for ca 10 min to achieve total dissolution. p-Toluenesulfonic acid (p-TSA, 50 mg) and phosphorous pentoxide (P2O5, 50 mg) were added, and then the stirred mixture was heated to 11O0C (oil bath) for 2 h under nitrogen. After cooling down to room temperature, CH2Cl2 (180 mL) was added to dissolve the brown slurry and the solution was washed by water (60 mL x 2), brine and then dried over Na2SO4. After filtration, the solvent was removed under reduced pressure. The product was purified by column chromatography over silica gel (10% (v/v) EtOAc/hexanes) to give 1.24 g (88%) of red oil. 1H NMR (400 MHz): δ 11.89 (d, J = 11.6, IH, OH/CH), 7.23 (m, 2Η, ArH-ortho), 7.10 (dt, J = 12.0, 1.0, IH, CHN), 6.98-6.93 (m, 3Η, AxH-para + AiH-meta), 2.45-2.42 (m, 2H,CH2), 2.04-2.00 (m, 2Η, CH2), 1.78-1.61 (m, 8Η, CH2), 1.47-1.41 (m, 2Η, CH2). 13C NMR (100 MHz): δ 206.0, 142.1, 140.6, 129.5, 122.6, 115.7, 104.6, 53.5, 39.3, 36.7, 28.9, 26.2, 21.4.
Ti complex Ic. The Ti complex Ic was synthesized following the procedure to make Ia. Thus, ligand 7-phenyliminomethyl-spiro[4,5]decan~6-one (1.24 g, 4.86 mmol) was reacted with «-BuLi (1.6 M in hexanes, 3.03 mL, 4.86 mmol) and then TiCl4 (1.0 M in toluene, 2.43 mL, 2.43 mmol) to give a deep read powder (81 mg, 6%). 1H NMR (toluene- d%, 400 MHz): δ 7.02-6.84 (m, 12H, CHN+ArH), 2.39 (m, 2Η, CH2), 1.92 (m, 2Η, CH2), 1.80 (m, 4Η, CH2), 1.46-1.02 (m, 18Η, CH2), 0.70 (m, 2Η, CH2). 13C NMR (tonuene-<4 100 MHz): δ 182.2, 165.0, 154.6, 128.3, 125.8, 123.9, 112.3, 48.9, 40.1, 37.7, 36.9, 27.7, 26.6.
Example IV
Synthesis of (III) where M is Ti, X is Cl, R is H and R3 is 2.6-F7Ph - Compound Id
The synthesis of Compound Id is set forth below. 7-[2,6-Difluoro-phenylimino)-methyl]-spiro[4,5]decan-6-one. The procedure to make N-phenyl analogue was followed. Thus, spiroaldehyde (0.72 g, 4.01 mmol) was reacted with 2,6-difluoroaniline (0.62 g, 4.81 mmol) in the presence of/j-toluenesulfonic acid (40 mg) and P2O5 (50 mg) to afford 1.04 g (89%) of pure product as a yellow oil after column chromatography over silica gel (10% (v/v) EtOAc/hexanes). 1H NMR (300 MHz): δ 11.88 (d, J = 11.3, IH, OYHCH), 7.30 (d, J = 1 1.5, IH, CHN), 6.87-6.79 (m, 3Η, ArH), 2.42 (t, J = 5.4, 2Η, CH2), 2.09-2.00 (m, 2Η, CH2), 1.79-1.60 (m, 8Η, CH2), 1.48-1.40 (m, 2Η, CH2). 13C NMR (75 MHz): δ 207.0, 153.8, (dd, JCF = 246.2, 5.8), 144.3 (t, JCF = 6.4), 121.6 (t, JCF = 9.7), 119.3 (t, JCF = 12.6), 112.3 (dd, JCF = 16.0, 7.7), 106.6, 54.1, 39.4, 36.8, 29.2, 26.4, 21.5. 19F NMR (282 MHz): δ -126.2.
Ti complex Id. The Ti complex Id was synthesized following the procedure to make Ia. Thus, ligand 7-[(2,6-difluoro-phenylimino)-methyl-spiro[4,5]decan-6-one (1.03 g, 3.54 mmol) was reacted with «-BuLi (1.6 M in hexanes, 2.21 mL, 3.54 mmol) and then TiCl4 (1.0 M in toluene, 1.77 mL, 1.77 mmol) gave a deep red powder that was crystallized from toluene to give the desired complex as a deep red crystalline solid (0.83g, 67%). 1H NMR (toluene-^, 400 MHz): δ 7.07 (s, 2H, CHN), 6.55 (m, 4Η, ArH), 6.38 (m, 2Η, ArH), 2.20- 0.80 (m, 28Η, CH2). 13C NMR (toluene-^, 100 MHz): δ 184.7, 169.7, 127.1, 112.2, 112.0, 111.9, 111.0, 49.4, 40.1, 37.7, 36.9, 27.7, 26.6. 19F NMR (toluene-flfe, 376 MHz): δ -116.1, - 118.2. Anal Calcd for C34H36Cl2F4N2O2Ti: C, 58.39; H, 5.19; N, 4.01. Found: C, 58.45; H, 4.98; N, 3.79.
Example V
Synthesis of (III) where M is Ti, X is Cl, R is H. R3 is 3.5-F7 Ph - Compound Ie
The synthesis of Compound Ie is set forth below.
7-[3,5-Difluoro-phenylimino)-methyl]-spiro[4,5]decan-6-one. The procedure to make N-phenyl analogue was followed. Thus, spiroaldehyde (1.04 g, 5.77 mmol) was reacted with 3,5-difluoroaniline (0.91 g, 6.92 mmol) in the presence ofp-toluenesulfonic acid (50 mg) and P2O5 (50 mg) to afford 1.35 g (81%) of pure product as a light yellow oil after column chromatography over silica gel (10% (v/v) EtOAc/hexanes). 1H NMR (400 MHz): δ 11.72 (d, J - 11.6, IH, CH/OH), 6.87 (dt, J = 1 1.6, 1.1, IH, CHN), 6.39 (dd, J = 9.0, 2.2, 2Η, AvH-ortho), 6.30 (tt, J = 8.9, 2.2, IH, kxH-parά), 2.82 (t, J - 5.6, 2H, CH2), 1.97-1.92 (m, 2Η, CH2), 1.72-1.56 (m, 8Η, CH2), 1.41-1.36 (m, 2H, CH2). 13C NMR (100 MHz): δ 207.4, 165.4, 162.9, 143.5, 140.1, 106.7, 98.7, 97.5, 54.1, 39.4, 36.8, 29.2, 26.4, 21.5. 19F NMR (376 MHz): δ -108.9.
Ti complex Ie. The Ti complex Ie was synthesized following the procedure to make Ia. Thus, ligand 7-[(3,5-difluoro-phenylimino)-methyl]-spiro[4.5]decan-6-one (0.68 g, 2.33 mmol) was reacted with «-BuLi (1.6 M in hexanes, 1.46 mL, 2.33 mmol) and then TiCl4 (1.0 M in toluene, 1.17 mL, 1.17 mmol) to give a deep red powder that was crystallized from toluene to give the desired complex as a deep red crystalline solid (0.088 g, 11%). 1H NMR (toluene-Jg, 400 MHz): δ 6.74(s, 2H, CHN), 6.46 (dd, J = 8.7, 1.9, 4Η, ArH), 6.34 (tt, J = 9.0, 2.3, 2Η, ArH), 2.36 (m, 2Η, CH2), 2.10-1.76 (m, 8Η, CH2), 1.49-1.13 (m, 16Η, CH2), 0.85 (m, 2Η, CH2). 13C NMR (toluene-J8, 100 MHz): δ 184.2, 165.6, 164.2, 161.7, 156.3, 113.1, 107.9, 101.3, 49.4, 40.3, 37.6, 36.8, 27.8, 26.6. 19F NMR (toluene-^, 376 MHz): δ -109.51.
Example VI
Synthesis of (III) where M is Ti, X is Cl, R is H and R3 is FsPh - Compound If
The synthesis of Compound If is set forth below.
7-(Pentafluorophenylimino-methyl)-spiro[4,5]decan-6-one. The procedure to make N-phenyl analogue was followed. Thus, spiroaldehyde (0.66 g, 3.66 mmol) was reacted with 2,3,4,5,6-pentafluoroaniline (0.81 g, 4.42 mmol) in the presence ofp- toluenesulfonic acid (40 mg) and P2O5 (50 mg) to afford 1.10 g (87%) of pure product as light yellow crystals after column chromatography over silica gel (10% (v/v) EtOAc/hexanes). 1H NMR (500 MHz): δ 1 1.84 (d, J = 1 1.0, IH, CH/OH), 7.16 (d, J = 11.3, IH, CHN), 2.44 (m, 2Η, CH2), 2.06-2.00 (m, 2Η, CH2), 1.78-1.75 (m, 2Η, CH2), 1.73-1.66 (m, 6Η, CH2), 1.49-1.43 (m, 2Η, CH2). 13C NMR (125 MHz): δ 208.2, 142.3, (t, J = 6.1), 140.0-139.4 (m), 138.1-136.9 (m), 135.2-134.9 (m), 117.7 (td, J = 10.7, 4.1), 108.5, 54.5, 39.4, 36.7, 29.3, 26.4, 21.4. 19F NMR (376 MHz): δ -156.24 (d, JFF = 21.4), -163.07 (td, JFF = 21.4, 4.6), -166.08 (tt, JFF = 21.4, 4.6). Anal Calcd for Ci7H16F5NO: C, 59.13; H, 4.67; N, 4.06. Found: C, 59.18; H, 4.60; N, 3.96. Ti complex If. The Ti complex If was synthesized following the procedure to make Ia. Thus, ligand 7-[(pentafluorophenylimino)-methyl]-spiro[4,5]decan-6-one (1.08 g, 3.13 mmol) was reacted with «-BuLi (1.6 M in hexanes, 1.96 mL, 3.13 mmol) and then TiCl4 (1.0 M in toluene, 1.57 mL, 1.57 mmol) to give a deep red powder that was crystallized from toluene to give the desired complex as a deep red crystalline solid (0.80 g, 63%). 1H NMR (toluene-^, 400 MHz): δ 6.91 (s, 2H, CHN), 2.31-2.25 (m, 2Η, CH2), 2.07-1.95 (m, 2Η, CH2), 1.75-1.69 (m, 2Η, CH2), 1.59-1.56 (m, 2Η, CH2), 1.34-1.10 (m, 2Η, CH2), 0.88-0.83 (m, 2Η, CH2). 13C NMR (toluene-</8, 100 MHz): δ 187.0, 170.2, 1 12.7, 49.8, 40.2, 37.4, 36.5, 27.6, 26.4, 26.1. 19F NMR (376 MHz): δ -145.6, -146.9, -158.9, -159.9, -162.6. Anal Calcd for C34H30Cl2Fi0N2O2Ti: C, 50.58; H, 3.75; N, 3.47. Found: C, 50.66; H, 3.52; N, 3.21.
Example VII
Synthesis of (III) where M is Zr, X is Cl, R is CF^ and R3 is Ph - Compound Ig
Compound Ig is synthesized as follows: The ligand 7-(2,2,2-trifluoro-l-phenylimino- ethyl)-spiro[4.5]decane-6-one is synthesized as described in Example I. A solution of the ligand in toluene is added to a solution of tetrakis(dimethylamino) zirconium in toluene solvent at room temperature, leading to an immediate color change from light yellow to orange, and then dark red. The resulting solution is stirred overnight to afford after solvent removal the complex L2Zr(NMe2)2. Then the complex L2Zr(NMe2)2 is dissolved in methylene chloride, and an excess (ca. 10 equivalent) of chlorotrimethylsilane is added. After stirring overnight at 22°C, the solvent is removed under vacuum. The dark red residue is triturated with pentane to afford a yellow solid.
Example VIII
Synthesis of (III) where M is Hf, X is Cl. R is CFj and R3 is Ph - Compound Ih
Compound Ih is synthesized as follows: The ligand 7-(2,2,2-trifluoro-l- phenylimino-ethyl)-spiro[4,5]decane-6-one is synthesized as described in Example I. A solution of the ligand in toluene is added to a solution of tetrakis(dimethylamino) hafnium in toluene solvent at room temperature, leading to an immediate color change. The resulting solution is stirred overnight to afford after solvent removal the complex L2Hf(NMe2)2. Then the complex L2Hf(NMe2)2 is dissolved in methylene chloride, and an excess (ca. 10 equivalent) of chlorotrimethylsilane is added. After stirring overnight at 220C, the solvent is removed under vacuum. The residue is triturated with pentane to afford compound Ih as a solid.
Example IX
Synthesis of (IV) where L is Ph3P, X is Ph, M is Ni, R is CF^ and R3 is Ph - Compound Ii
Compound Ii is synthesized as follows: The ligand 7-(2,2,2-trifiuoro-l-phenylimino- ethyl)-spiro[4,5]decane-6-one is synthesized as set forth in Example I. The ligand is deprotonated in toluene solvent with one equivalent n-butyllithium at -780C. Then one equivalent of /ra«s-[(Ph3P)2NiPh(Cl)] in toluene is added. After stirring overnight at 220C, the suspension is filtered to remove LiCl. Upon concentration of the toluene, crystals of Compound Ii are grown and isolated after decanting the mother liquor.
Example X
Polymerization of Ethylene
Polymerizations of ethylene were carried out with Ia, Ib, Ic, Id, Ie and If upon activation with methylaluminoxane (MAO). The polymerization conditions are as follows: 10 psi ethylene, 0.01 mmol catalyst, 80 ml toluene, 1.5 mmol MAO. Results obtained are set forth in said Table 1 below.
Table 1
Polymerization of Ethylene with Ia - If / PMAO
Figure imgf000016_0001
Conditions: 0.01 mmol catalyst; 80 mL toluene; 1.5 mmol PMAO, [Al]: [Ti] = 150, 10 psi ethylene.
When activated with MAO, these complexes are active for the polymerization of ethylene at 0 to 50 0C (Table 1). The activity of compound Ia was found to be higher than that of the analogous phenoxyketimine catalyst.
As shown in Table 1, living polymerization was obtained with all the complexes in the range of 0 to 25 0C including the CF3 substituted ketimine catalysts Ia and Ib.
The polymerization results for Compound Ib and Ie with various reaction times are shown in Tables 2 and 3 below, respectively.
Table 2
Polymerization of Ethylene with Ib / PMAO
Figure imgf000016_0002
Figure imgf000017_0001
Table 3
Polymerization of Ethylene with Ie / PMAO
Figure imgf000017_0002
All the polyethylene products exhibited melting points in the range of 131 to 1350C.
The 13C I N NMMRR a annaallyyssiis indicates that these PE samples have linear structures with non- detectable branching.
Example XI
Polymerization of Propylene
Polymerization of propylene was carried out with Ia, Ib, Id, Ie and If. When R3 in the ligand was unsubstituted phenyl (ligand (Ic)), the catalyst was not active for propylene polymerization. Conditions and results are shown in Table 4 below.
Table 4
Polymerization of Propylene with Ia - If / PMAO
Figure imgf000017_0003
Figure imgf000018_0001
Conditions 0 02 mmol catalyst (Ti complex), O0C, 6h, 80 mL toluene, 30 psi propylene a) 0 01 mmol cat , 4 hours B) Not active
Fluorine atoms at the ortho position of N-aryl of R3 (Ib and Id) led to production of atactic polypropylene while fluorine atoms at meta positions of TV-aryl of R3 (Ie) led to syndio-enπched polypropylene ([rrrr] = 0 40) Pentafluoro substituted N-aryl catalyst (If) generated iso-ennched polypropylene ([mmmm] = 0 20)
Polymerization of propylene was carried out with Ig by using two different activators When methylalummoxane (MAO) was used, atactic polypropylene was produced (Turnover Frequency (TOF): 30.4 mol P/mol Zr-h; Mn = 508 600, PDI = 1.69) When ι- Bu3 Al/Ph3C+B(C6F5)4~ was used as activator, iso-ennched polypropylene was generated (TOF = 129.8 mol P/mol Zr-h; bimodal GPC trace, PDI = 2.86).
Example XII
Polymerization of Cvclopentene
Polymerization is conducted m a 3-ounce Lab-Crest™ pressure reaction vessel equipped with a magnetic stir bar The reactor is first conditioned under dynamic vacuum and high temperature and then charged with a 3 mmol of PMAO in toluene and 5 mL of cyclopentene under nitrogen. Then 20 mmol of CAT is dissolved in toluene (3 mL) at room temperature under nitrogen The solution is then added to the reactor using a syringe. Finally, the reactor is adjusted at 700C After 16 h, the reactor contents are poured into methanol/HCl and polymer is isolated by filtration.
Example XIII
Polymerization of Norbornene
Polymerization is conducted in a 3-ounce Lab-Crest™ pressure reaction vessel equipped with a magnetic stir bar. The reactor is under dynamic vacuum and high temperature and then charged with a 3 mmol of PMAO in toluene and 5 mL of norbornene under nitrogen Then 20 mmol of CAT is dissolved in toluene (3 mL) at room temperature under nitrogen The solution is then added to the reactor using a syringe. Finally, the reactor is adjusted at 700C. After 16 h, the reactor contents are poured into methanol/HCl and polymer is isolated by filtration.
Example XIV
Cvclopentene/Ethylene Copolymerization
Polymerization is conducted in a 3-ounce Lab-Crest™ pressure reaction vessel equipped with a magnetic stir bar. In a typical polymerization experiment, the reactor is charged with 6 mmol of PMAO in toluene under nitrogen. Then 13.2 mL of cyclopentene is introduced. CAT is dissolved in toluene (5 mL) at room temperature under nitrogen. The solution is then added to the reactor via syringe, such that the fixed [A1]/[M] ratio is 150. Finally, the reactor is pressurized with ethylene gas and adjusted to the desired pressure and temperature. After the desired period of time, the reactor is vented. The polymer is precipitated from methanol/HCl, filtered, and then dried in vacuo to constant weight.
Example XV
Propylene/Ethylene Copolymerization
A 6-ounce Lab-Crest™ pressure reaction vessel equipped with a magnetic stir bar is first conditioned under dynamic vacuum and high temperature and then charged with PMAO (0.31 g, 5.3 mmol) and toluene (100 mL). The reactor is then equilibrated at 00C. At this point, the reactor atmosphere is exchanged with propylene three times, and then the solution is saturated under propylene pressure (30 psi). An overpressure of ethylene (33 psi) is then introduced to the reactor and a toluene solution (4 mL) of CAT (0.01 mmol, [A1]/[M] = 500), is added via syringe. After 1 h, the reactor is vented and the polymer is precipitated in methanol/HCl, filtered, washed with methanol, and then dried in vacuo to constant weight.
Variations
The foregoing description of the invention has been presented describing certain operable and preferred embodiments. It is not intended that the invention should be so limited since variations and modifications thereof will be obvious to those skilled in the art, all of which are within the spirit and scope of the invention.

Claims

WHAT IS CLAIMED IS:
1. Compound having the structure :
Figure imgf000020_0001
where M is selected from the group consisting of titanium, zirconium and hafnium; where X is selected from the group consisting of halogens, Ci-C20 hydrocarbons, Ci-C20 alkoxides and Ci-C20 amides; where R is selected from the group consisting of hydrogen, Ci-C20 hydrocarbons, Ci-C2O fluorocarbons and C3-C2O heterocycles; where R1 is selected from the group consisting Of C2-C20 hydrocarbons bound by a tetrahedral carbon atom, i.e., where carbon alpha to carbonyl carbon, i.e., the carbon bonded to oxygen of ketoimine moiety, of ketoimine moiety is a tetrahedral carbon; R2 is selected from the group consisting of hydrogen, Ci-C20 hydrocarbons, Ci-C20 fluorocarbons and C3-C20 heterocycles; R3 is selected from the group consisting Of Ci-C20 hydrocarbons, Ci-C20 fluorocarbons and C3-C20 heterocycles; where two or more of R, R1, R2 and R3 can be bonded together to form a ring; or having the structure:
Figure imgf000020_0002
where M is selected from the group consisting of nickel and palladium, L is a neutral two electron donor (i.e., an uncharged group which fulfills the function of filling the coordination valance of M, e.g., an ether, phosphine or nitrile group), X, R, R1, R2 and R3 are defined as above and where two or more of R, R , R and R can be bonded together to form a ring.
2. The compound of Claim 1 having the structure (I) where M is titanium.
3 3.. T Thhee c coommppooiuind of Claim 1 where R1 and R2 are bonded together to form spiro[4,5]decan-6-onato.
4. The compound of Claim 3 where M is titanium or zirconium, X is selected from the group consisting of halogens and Ci-C20 hydrocarbons, and R3 is selected from the group consisting of phenyl and fluorinated aryl.
5. The compound of Claim 4 where X is Cl and R is hydrogen or CF3.
6. The compound of Claim 4 which contains at least one fluorine atom.
7. The compound of Claim 1 having the structure (II) where R1 and R2 are bonded together to form spiro[4.5]decane-6-onato.
8. The compound of Claim 7 where X is Cl, R is hydrogen or CF3 and R3 is selected from the group consisting of phenyl and fluorinated phenyl.
9. A method for the polymerization of ethylene, comprising the step of polymerizing ethylene in the presence of a catalytically effective amount of activated compound of Claim 1, thereby producing polyethylene of Mn in the range of 1,000 to 3,000,000 g/mol and PDI in the range of 1 to 3.
10. A method for the polymerization of ethylene, comprising the step of polymerizing ethylene in the presence of a catalytically effective amount of compound of Claim 5 activated by an activating effective amount of methylaluminoxane, thereby to produce polyethylene of Mn in the range of 1,000 to 3,000,000 g/mol and PDI in the range of 1 to 3.
11. A method for polymerization of a C3-Ci0 alpha olefin, comprising the step of polymerizing the C3-Ci0 alpha-olefin in the presence of a catalytically effective amount of activated compound of Claim 1, thereby producing poly(C3-Ci0 alpha olefin) of Mn in the range of 1,000 to 3,000,000 g/mol and PDI in the range of 1 to 3.
12. The method of Claim 11 where said compound contains at least one fluorine atom.
13. A method for the polymerization of a C3-Ci0 alpha olefin, such method comprising the step of polymerizing the C3-Ci0 alpha-olefin in the presence of a catalytically effective amount of the compound of Claim 6 activated by an activating effective amount of methylaluminoxane, thereby to produce poly(C3-Cio alpha olefin) of Mn in the range of 1,000 to 3,000,000 g/mol and PDI in the range of 1 to 3.
14. A method for the polymerization of a C4-Ci0 cyclic alkene, comprising the step of polymerizing C4-Ci0 cyclic alkene in the presence of a catalytically effective amount of activated compound of Claim 1, thereby to produce poly(C4-Ci0 cyclic alkene) having Mn ranging from 1,000 to 3,000,000 g/mol.
15. A method for polymerization of a C4-Ci0 cyclic alkene comprising the step of polymerizing C4-Ci0 cyclic alkene in the presence of a catalytically effective amount of compound of Claim 5 activated by an activating effective amount of methylaluminoxane, thereby to produce poly(C4-Ci0 cyclic alkene) having Mn ranging from 1,000 to 3,000,000 g/mol.
16. A method for copolymerizing ethylene and a comonomer selected from the group consisting Of C3-Ci0 alpha olefin, styrene, C3-Ci0-diene, C2-Ci0 alkenyl chloride and C4-Ci0 cyclic alkene, comprising the step of copolymerizing ethylene and said comonomer in a mole ratio of ethylene to comonomer ranging from 1:99 to 99:1, in the presence of a catalytically effective amount of activated compound of Claim 1, thereby to produce copolymer of ethylene and said comonomer having Mn ranging from 1,000 to 3,000,000 g/mol.
17. The method of Claim 16 where when the comonomer comprises C3-C]0 alpha olefin, said compound contains at least one fluorine atom.
18. A method for copolymerizing ethylene and a comonomer selected from the group consisting Of C3-Ci0 alpha olefin, styrene, C3-Ci0 diene, C2-Ci0 alkenyl halide and C4- Cio cyclic alkene, comprising the step of copolymerizing ethylene and said comonomer in a mole ratio of ethylene to comonomer ranging from 1 :99 to 99:1, in the presence of a catalytically effective amount of compound of Claim 5 activated by an activating effective amount of methylaluminoxane, thereby to produce copolymer of ethylene and said comonomer having Mn ranging from 1,000 to 3,000,000 g/mol.
19. The method of Claim 18 where when the comonomer comprises C3-Ci0 alpha olefin, said compound contains at least one fluorine atom.
PCT/US2005/027927 2004-08-18 2005-08-08 Alkene polymerization using beta-ketoiminato metal complexes Ceased WO2006023296A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2007527858A JP2008510001A (en) 2004-08-18 2005-08-08 Alkene polymerization using β-ketoiminato metal complex
US11/629,985 US20090192278A1 (en) 2004-08-18 2005-08-08 Alkene polymerization using beta-ketoiminato metal complexes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60232004P 2004-08-18 2004-08-18
US60/602,320 2004-08-18

Publications (2)

Publication Number Publication Date
WO2006023296A2 true WO2006023296A2 (en) 2006-03-02
WO2006023296A3 WO2006023296A3 (en) 2006-11-16

Family

ID=35968056

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/027927 Ceased WO2006023296A2 (en) 2004-08-18 2005-08-08 Alkene polymerization using beta-ketoiminato metal complexes

Country Status (3)

Country Link
US (1) US20090192278A1 (en)
JP (1) JP2008510001A (en)
WO (1) WO2006023296A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101079326B1 (en) * 2008-09-26 2011-11-04 코오롱인더스트리 주식회사 Catalyst and Coordination Polymer of Dicyclopentadiene
KR101279104B1 (en) 2011-07-12 2013-06-26 롯데케미칼 주식회사 transition metal complexes and method for preparing a polyethylene terephthalate using the same

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404341B2 (en) 2006-01-26 2013-03-26 Outlast Technologies, LLC Microcapsules and other containment structures for articles incorporating functional polymeric phase change materials
US9234059B2 (en) * 2008-07-16 2016-01-12 Outlast Technologies, LLC Articles containing functional polymeric phase change materials and methods of manufacturing the same
US20100016513A1 (en) * 2008-07-16 2010-01-21 Outlast Technologies, Inc. Functional Polymeric Phase Change Materials and Methods of Manufacturing the Same
US20100012883A1 (en) * 2008-07-16 2010-01-21 Outlast Technologies, Inc. Functional Polymeric Phase Change Materials
US20100015430A1 (en) * 2008-07-16 2010-01-21 Outlast Technologies, Inc. Heat Regulating Article With Moisture Enhanced Temperature Control
US8221910B2 (en) 2008-07-16 2012-07-17 Outlast Technologies, LLC Thermal regulating building materials and other construction components containing polymeric phase change materials
US8673448B2 (en) 2011-03-04 2014-03-18 Outlast Technologies Llc Articles containing precisely branched functional polymeric phase change materials
CN102399323B (en) * 2011-10-09 2014-05-14 南昌大学 N,O-single ligand metal catalyst with stereochemical structure and preparation method thereof
US10003053B2 (en) 2015-02-04 2018-06-19 Global Web Horizons, Llc Systems, structures and materials for electrochemical device thermal management
US10431858B2 (en) 2015-02-04 2019-10-01 Global Web Horizons, Llc Systems, structures and materials for electrochemical device thermal management

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410664B1 (en) * 1997-03-24 2002-06-25 Cryovac, Inc. Catalyst compositions and processes for olefin polymers and copolymers
GB9721559D0 (en) * 1997-10-11 1997-12-10 Bp Chem Int Ltd Novel polymerisation catalysts
TW562810B (en) * 1998-04-16 2003-11-21 Mitsui Chemicals Inc Catalyst for olefinic polymerization and method for polymerizing olefine
US6545108B1 (en) * 1999-02-22 2003-04-08 Eastman Chemical Company Catalysts containing N-pyrrolyl substituted nitrogen donors
KR20020009617A (en) * 1999-05-21 2002-02-01 스타르크, 카르크 Method of Producing Rubber Compositions in Styrene Solutions with Sterically Superior Chelate Catalysts
KR100844062B1 (en) * 2001-02-21 2008-07-07 미쓰이 가가쿠 가부시키가이샤 Catalyst for olefin polymerizaion and method for producing olefin polymers using the catalyst
JP3994015B2 (en) * 2001-02-21 2007-10-17 三井化学株式会社 Olefin polymerization catalyst and process for producing olefin polymer using the catalyst
US6562930B2 (en) * 2001-09-18 2003-05-13 Cornell Research Foundation, Inc. Bis(salicylaldiminato)titanium complex catalysts, highly syndiotactic polypropylene by a chain-end control mechanism, block copolymers containing this
CN1176953C (en) * 2002-12-27 2004-11-24 中国科学院长春应用化学研究所 A kind of β-diketoimine titanium olefin polymerization catalyst
CN1544493A (en) * 2003-11-27 2004-11-10 中国科学院长春应用化学研究所 Synthetic method of ethylene and methyl methacrylate copolymer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101079326B1 (en) * 2008-09-26 2011-11-04 코오롱인더스트리 주식회사 Catalyst and Coordination Polymer of Dicyclopentadiene
KR101279104B1 (en) 2011-07-12 2013-06-26 롯데케미칼 주식회사 transition metal complexes and method for preparing a polyethylene terephthalate using the same

Also Published As

Publication number Publication date
WO2006023296A3 (en) 2006-11-16
JP2008510001A (en) 2008-04-03
US20090192278A1 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
AU2001275070B2 (en) Catalysts for olefin polymerization
US20080177020A1 (en) Non-metallocene organometallic complexes and related methods and systems
WO2003006512A1 (en) Method for catalytic polymerization using an ultra-high activity non-metallocene pre-catalyst
WO2002036638A2 (en) Active non-metallocene pre-catalyst and method for tactic catalytic polymerization of alpha-olefin monomers
JP2018513103A (en) Olefin oligomerization method
AU6794300A (en) 2-alkyl-4-(2,6-dialkylphenyl) indenes
WO2006023296A2 (en) Alkene polymerization using beta-ketoiminato metal complexes
WO2011049349A2 (en) Method for preparing a metallocene-supported catalyst, and metallocene-supported catalyst prepared by the method
RS56521B1 (en) Catalysts for preparing ultra high molecular weight polyethylene (uhmwpe)
NO324616B1 (en) Single carbon bonds with cyclopentadienyl compounds and metallocene complexes thereof
KR102024328B1 (en) Metallocene compounds, catalyst compositions comprising the same, and method for preparing olefin polymers using the same
JPH09183788A (en) Metallocene compound
CN104245712B (en) Ethylene oligomerisation processes
WO2012036443A2 (en) Dinuclear metallocene compound and a production method for polyolefins using the same
CN107298727A (en) A kind of preparation and application of double salicylaldehyde imines anthracene bimetallic titanium catalyst
US7595413B2 (en) Phosphine-substituted vinyl containing metallocene catalyst, preparation process and the application of the same
Pan et al. N-heterocyclic carbene scandium complexes: synthesis, structure, and catalytic performance for α-olefin polymerization and copolymerization with 1, 5-hexadiene
EP1994040A1 (en) Polymerisation of ethylene and alpha-olefins with phosphino-iminophenol complexes
JP5186559B2 (en) Novel tridentate ligand compound having an iminofuran unit, a process for the preparation of this compound and its use in the preparation of catalysts for the homopolymerization of ethylene and copolymerization with α-olefins
EP4157527A1 (en) Homogeneous single site catalyst and its use in preparaing linear polyethylene
CN101376663A (en) 6-benzimidazole-pyridine-2- formiate amide metal complexe, preparation and use
KR20170009597A (en) Metallocene compounds, catalyst compositions comprising the same, and method for preparing olefin polymers using the same
KR101238785B1 (en) Multinuclear nonmetallocene compounds and process for preparation of olefin polymers using the same
EP1640378A1 (en) Metallocene catalysts comprising monocyclic multisiloxy substituted cyclopentadienyl group(s) for the polymerisation of olefins
CN120058786A (en) CNN-tridentate coordination titanium zirconium hafnium metal catalyst and preparation of high-melting-point polyolefin block copolymer thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11629985

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2007527858

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05807361

Country of ref document: EP

Kind code of ref document: A2